Recent investigations demonstrate the promise of RMP1-14, a newly engineered anti-mouse PD-1 reagent , for boosting tumor immunotherapy . Unlike existing approaches, RMP1-14 exhibits enhanced https://www.targetmol.com/compound/anti_mouse_pd_1_antibody_rmp1_14